Abstract
Disclosures
No relevant conflicts of interest to declare.
Author notes
*
Asterisk with author names denotes non-ASH members.
![](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/128/22/10.1182_blood.v128.22.632.632/2/m_inf01.gif?Expires=1722350671&Signature=YWxsoTawd39kD~rNeBCu~KVR7a6Kd7-uQ2ZP-PNPRfx9Lhyg8WYqeEYFvob~YOg7J7k4MqqgwcPQRFVKTQLwlTrUvSf276jjy9BvDCnfE6XlWgTa4lxyfaA9nCnRck7maaheSnc2-Ff-Xhm3PRmO82mLnaMt5D1yYrGpjIaqCIrQiYFFeHtE3Cde4TgxVZKYf4a99lT5HrlRPfJGiHsbLTDLfCjyYO4279XF8uF7zxiq~y0RsrUMUyrZ4~Dvf6GkfCmpKID5VR4uXa35TQh5vGAc8xqoAthUY9CXKCXHNwkRsbG25IN7leci71vrRuWcfrx1Dn2UCaLMtf4RbNlflA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
This icon denotes a clinically relevant abstract
© 2016 by The American Society of Hematology
2016
Sara Rohrabaugh, Meenu Kesarwani, Zachary Kincaid, Erika Huber, H. Leighton Grimes, Mohammad Azam; Enhanced MAPK Signaling Constitute Non-Oncogene Addiction in CSF3R Induced Leukemia. Blood 2016; 128 (22): 632. doi: https://doi.org/10.1182/blood.V128.22.632.632
Download citation file:
No relevant conflicts of interest to declare.
Asterisk with author names denotes non-ASH members.
This icon denotes a clinically relevant abstract
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals